<DOC>
	<DOCNO>NCT01205646</DOCNO>
	<brief_summary>The primary goal trial ass change PET scan administration zoledronate ( bisphosphonate ) therapy patient metastatic prostate cancer . It establish zoledronate therapy may play role delay reduce incidence skeletal event . Researchers propose evaluate change uptake value FMAU PET scan zoledronate therapy . It demonstrate FMAU PET scan successfully demonstrate detect bony metastatic site prostate cancer . In addition , investigator would like evaluate change level prostate-specific antigen ( PSA ) patient well outcome bone scan .</brief_summary>
	<brief_title>PET Scanning Evaluate Zoledronate Efficacy Metastatic Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Histological diagnosis prostate cancer Evidence metastatic disease radiologic criterion Bone scan within 4 week start therapy Creatinine within 2 week registration , calculate creatinine clearance &gt; 60ml/min . Minimum life expectancy 6 month Willingness pretherapy PET scan perform within 2 week registration post therapy PET scan perform within 1 week dose Zometa ( total 3 PET scan require ) Calculated creatinine clearance &gt; 50ml/min . No prior Zoledronate therapy Patients must disease progression despite testosterone suppression ( level &lt; 50ng/ml ) ; progression rise PSA ( least 2 value least 2 week apart ) new lesion scan progression exist lesion CT scan . No concomitant systemic therapy metastatic prostate cancer allow except LHRH analogue continue necessary maintain testosterone suppression . No concomitant radiation therapy Prior RT allow complete least 2 week prior registration . Presence measurable evaluable disease If RT administer , disease outside RT port require . Willingness sign inform consent . Registration willingness sign inform consent separate PET protocol 2335 describe PET scan procedure . Patients must good oral hygiene include recent dental evaluation Patients unable swallow Patients dental cavity likely need dental extraction root canal treatment management</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>prostate cancer</keyword>
	<keyword>metastatic</keyword>
	<keyword>zoledronate</keyword>
	<keyword>zometa</keyword>
</DOC>